• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The significance of fractionation regimens in radiation and combined hyperthermia using a murine fibrosarcoma.

作者信息

Hahn E W, Alfieri A A, Kim J H

出版信息

Cancer. 1978 Dec;42(6):2596-9. doi: 10.1002/1097-0142(197812)42:6<2596::aid-cncr2820420613>3.0.co;2-i.

DOI:10.1002/1097-0142(197812)42:6<2596::aid-cncr2820420613>3.0.co;2-i
PMID:728862
Abstract

The significance of time-dose relationships in the use of local tumor hyperthermia (LTH) when combined with radiation (RAD) was studied in a murine fibrosarcoma. RAD, either alone or combined with LTH, was delivered in four equal fractions (total doses, 1.8 to 4.2 krad) separated by 1 to 4 days. LTH (43.1 C +/- .05 C for 15 minutes, water bath) was applied immediately after RAD. In this tumor system, RAD was most effective when delivered every 2nd or 3rd day, by a factor of 1.25 over the response achieved when the four fractions were delivered every 1 or 4 days. At all levels studied, RAD + LTH produced a superior tumor response compared to RAD alone. The ratio of the RAD + LTH/RAD doses to achieve an isobiological response ranged from 1.7 to 2.5. Most significant was the finding that the RAD + LTH treatment response was independent of the fractionation scheme used and more dependent on the total RAD dose delivered.

摘要

相似文献

1
The significance of fractionation regimens in radiation and combined hyperthermia using a murine fibrosarcoma.
Cancer. 1978 Dec;42(6):2596-9. doi: 10.1002/1097-0142(197812)42:6<2596::aid-cncr2820420613>3.0.co;2-i.
2
Single dose X-irradiation and concomitant hyperthermia on a murine fibrosarcoma.
Cancer. 1978 Dec;42(6):2591-5. doi: 10.1002/1097-0142(197812)42:6<2591::aid-cncr2820420612>3.0.co;2-#.
3
Multiple adjuvant therapy on a murine fibrosarcoma: actinomycin-D, X-irradiation and local tumor hyperthermia.对小鼠纤维肉瘤的多种辅助治疗:放线菌素-D、X射线照射和局部肿瘤热疗。
Radiology. 1978 Oct;129(1):225-7. doi: 10.1148/129.1.225.
4
Improved response of a murine fibrosarcoma (Meth-A) to interstitial radiation when combined with hyperthermia.当与热疗联合使用时,小鼠纤维肉瘤(Meth-A)对间质放射的反应得到改善。
Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2145-8. doi: 10.1016/0360-3016(84)90215-3.
5
Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.SR-4233在体外和体内FsaIIC小鼠纤维肉瘤肿瘤系统中与热疗和放疗的相互作用。
Cancer Res. 1990 Aug 15;50(16):5055-9.
6
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.优化影响美法仑在自发性小鼠肿瘤中热增强作用的因素。
Cancer Chemother Pharmacol. 2006 Dec;58(6):719-24. doi: 10.1007/s00280-006-0229-2. Epub 2006 Apr 14.
7
Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.联合热疗与放疗中附加热效应在治疗增益因子中的意义:小鼠肿瘤反应和足部反应
Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1561-8. doi: 10.1016/0360-3016(91)90333-y.
8
Fractionated hyperthermia given alone or with radiation.单独给予或与放疗联合给予分次热疗。
Front Radiat Ther Oncol. 1984;18:41-6. doi: 10.1159/000429198.
9
Interstitial radiation and hyperthermia in the Dunning R3327 prostate tumour model: therapeutic efficacy depends on radiation dose-rate, sequence and frequency of heating.邓宁R3327前列腺肿瘤模型中的间质放疗和热疗:治疗效果取决于放射剂量率、加热顺序和频率。
Int J Radiat Biol. 1996 Nov;70(5):609-16. doi: 10.1080/095530096144824.
10
Fractionation studies with combined X rays and hyperthermia in vivo.体内联合X射线和热疗的分次照射研究。
Br J Radiol. 1980 Apr;53(628):346-56. doi: 10.1259/0007-1285-53-628-346.

引用本文的文献

1
The Rationale for Combining Hypofractionated Radiation and Hyperthermia.超分割放疗与热疗联合应用的理论依据。
Cancers (Basel). 2024 Nov 22;16(23):3916. doi: 10.3390/cancers16233916.